Science
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Our science
Multiple Myeloma
Melflufen
Pipeline
Clinical Program
Treatment Principles
Investigator Initiated Trials
Pepaxti®
About
Learn more about the company Oncopeptides and the work we do to redefine cancer care
About us
Leadership
Responsibility
Corporate Governance
Career
Investors
Learn more about the company Oncopeptides and the work we do to redefine cancer care
For investors
The Share
Financial reports
General meeting
Financial Calendar
Newsroom

Search

Home
/
Newsroom
/
News
/
Test

August 27, 2026

News

Test

Investor

Share

Quick links

Investors
Multiple Myeloma
Pepaxti®
Pipeline
Contact
Whistleblowing

Investors
Multiple Myeloma
Pepaxti®
Pipeline
Contact
Whistleblowing

[mfn_subscription_widget widget_id=31b91279-88d9-4ddb-8093-385fef2482e2 lang=en]

Glossary
Cookies
Privacy Notice
Terms of Use

Glossary
Cookies
Privacy Notice
Terms of Use

© 2026 Oncopeptides AB (publ). All rights reserved.

Glossary
Cookies
Privacy Notice
Terms of Use

Glossary
Cookies
Privacy Notice
Terms of Use

Select language or region

Language

English

Region

Global

Germany
Spain
Austria
Italy

Germany
Spain
Austria
Italy

Search

Science

Learn more about the company Oncopeptides and the work we do to redefine cancer care

Multiple Myeloma
Melflufen
Pipeline
Clinical Program
Treatment Principles
Investigator Initiated Trials

About

Learn more about the company Oncopeptides and the work we do to redefine cancer care

Leadership
Responsibility
Corporate Governance
Career

Investors

Learn more about the company Oncopeptides and the work we do to redefine cancer care

The Share
Financial reports
General meeting
Financial Calendar

Newsroom

Learn more about the company Oncopeptides and the work we do to redefine cancer care

News
Oncopeptalks
Events
Media